128 related articles for article (PubMed ID: 32013368)
1. Evaluation of an Automated Yeasts Identification System for Identification of Yeast Isolates.
Er H; Koyuncu-Ozyurt O; Ozhak B; Yazisiz H; Eres-Saritas Z; Cetinkaya O; Ongut G; Ogunc D
Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013368
[TBL] [Abstract][Full Text] [Related]
2. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometric identification and antifungal susceptibility analysis of Candida species isolated from patients with invasive yeast infections in five university hospitals.
Hu Z; Zhang J; Chen Z; Jin Z; Leng P; Zhou J; Xie X
Braz J Microbiol; 2019 Jan; 50(1):99-105. PubMed ID: 30637643
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of MALDI-TOF Mass Spectrometry for Routine Identification of Candida Species in a Resource-Poor Setting.
Sow D; Fall B; Ndiaye M; Ba BS; Sylla K; Tine R; Lô AC; Abiola A; Wade B; Dieng T; Dieng Y; Ndiaye JL; Hennequin C; Gaye O; Faye B
Mycopathologia; 2015 Oct; 180(3-4):173-9. PubMed ID: 26016846
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of Phoenix™ Yeast ID Panel and API® ID 32C commercial systems for the identification of Candida species isolated from clinical samples].
Gayibova Ü; Dalyan Cılo B; Ağca H; Ener B
Mikrobiyol Bul; 2014 Jul; 48(3):438-48. PubMed ID: 25052110
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the identification results of Candida species obtained by BD Phoenix™ and Maldi-TOF (Bruker Microflex LT Biotyper 3.1).
Marucco AP; Minervini P; Snitman GV; Sorge A; Guelfand LI; Moral LL;
Rev Argent Microbiol; 2018; 50(4):337-340. PubMed ID: 29422351
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of a Commercial Multiplex Tandem Polymerase Chain Reaction Method for the Identification of the Yeasts Isolated from Blood Cultures].
Er H; Koyuncu Özyurt Ö; Özhak B; Yazısız H; Öngüt G; Eres Sarıtaş Z; Dönmez L; Çolak D; Günseren F; Öğünç D
Mikrobiyol Bul; 2020 Oct; 54(4):596-605. PubMed ID: 33107288
[TBL] [Abstract][Full Text] [Related]
7. [Identification of Candida yeasts: Conventional methods and MALDI-TOF MS].
Maldonado I; Cataldi S; Garbasz C; Relloso S; Striebeck P; Guelfand L; López Moral L; ;
Rev Iberoam Micol; 2018; 35(3):151-154. PubMed ID: 30078526
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of Candida species.
Lacroix C; Gicquel A; Sendid B; Meyer J; Accoceberry I; François N; Morio F; Desoubeaux G; Chandenier J; Kauffmann-Lacroix C; Hennequin C; Guitard J; Nassif X; Bougnoux ME
Clin Microbiol Infect; 2014 Feb; 20(2):153-8. PubMed ID: 23594150
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA Sequencing for a Wide Range of Clinically Isolated Yeast Species: Improved Identification by Combining 21-Plex PCR and API 20C AUX as an Alternative Strategy for Developing Countries.
Arastehfar A; Daneshnia F; Kord M; Roudbary M; Zarrinfar H; Fang W; Hashemi SJ; Najafzadeh MJ; Khodavaisy S; Pan W; Liao W; Badali H; Rezaie S; Zomorodian K; Hagen F; Boekhout T
Front Cell Infect Microbiol; 2019; 9():21. PubMed ID: 30828570
[TBL] [Abstract][Full Text] [Related]
11. [A comparison of the costs, reliability and time of result periods of widely used methods, new molecular methods and MALDI TOF-MS in the routine diagnosis of Candida strains].
Kal Çakmaklıoğulları E; Aşgın N; Değerli K
Mikrobiyol Bul; 2019 Apr; 53(2):204-212. PubMed ID: 31130124
[TBL] [Abstract][Full Text] [Related]
12. [Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry vs conventional methods in the identification of Candida non-albicans].
Martínez-Lamas L; Pérez del Molino ML; Pardo F; Varela E; Regueiro BJ
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):568-72. PubMed ID: 21782293
[TBL] [Abstract][Full Text] [Related]
13. Identification of yeast isolated from dermatological patients by MALDI-TOF mass spectrometry.
Seyfarth F; Wiegand C; Erhard M; Gräser Y; Elsner P; Hipler UC
Mycoses; 2012 May; 55(3):276-80. PubMed ID: 21848605
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of mass spectrometry for the identification of clinically interesting yeasts].
Galán F; García-Agudo L; Guerrero I; Marín P; García-Tapia A; García-Martos P; Rodríguez-Iglesias M
Enferm Infecc Microbiol Clin; 2015; 33(6):372-8. PubMed ID: 25444360
[TBL] [Abstract][Full Text] [Related]
15. Characterising atypical Candida albicans clinical isolates from six third-level hospitals in Bogotá, Colombia.
Rodríguez-Leguizamón G; Fiori A; López LF; Gómez BL; Parra-Giraldo CM; Gómez-López A; Suárez CF; Ceballos A; Van Dijck P; Patarroyo MA
BMC Microbiol; 2015 Oct; 15():199. PubMed ID: 26438104
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of mass spectrometry: MALDI-TOF MS for fast and reliable yeast identification].
Relloso MS; Nievas J; Fares Taie S; Farquharson V; Mujica MT; Romano V; Zarate MS; Smayevsky J
Rev Argent Microbiol; 2015; 47(2):103-7. PubMed ID: 25882136
[TBL] [Abstract][Full Text] [Related]
17. Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories?
Mizusawa M; Miller H; Green R; Lee R; Durante M; Perkins R; Hewitt C; Simner PJ; Carroll KC; Hayden RT; Zhang SX
J Clin Microbiol; 2017 Feb; 55(2):638-640. PubMed ID: 27881617
[No Abstract] [Full Text] [Related]
18. Yeast identification by sequencing, biochemical kits, MALDI-TOF MS and rep-PCR DNA fingerprinting.
Zhao Y; Tsang CC; Xiao M; Chan JFW; Lau SKP; Kong F; Xu Y; Woo PCY
Med Mycol; 2018 Oct; 56(7):816-827. PubMed ID: 29228397
[TBL] [Abstract][Full Text] [Related]
19. Rapid and reliable MALDI-TOF mass spectrometry identification of Candida non-albicans isolates from bloodstream infections.
Pulcrano G; Iula DV; Vollaro A; Tucci A; Cerullo M; Esposito M; Rossano F; Catania MR
J Microbiol Methods; 2013 Sep; 94(3):262-6. PubMed ID: 23845229
[TBL] [Abstract][Full Text] [Related]
20. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry.
Aslani N; Janbabaei G; Abastabar M; Meis JF; Babaeian M; Khodavaisy S; Boekhout T; Badali H
BMC Infect Dis; 2018 Jan; 18(1):24. PubMed ID: 29310582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
